// App-Quantinova.ai

CTIM-27 : AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL

Researchers

Presenter

  • Linda M Liau

Principal Investigators

  • Steven Brem

  • Jian Campian

  • John Trusheim

  • Fabio Iwamoto

  • David Tran

  • George Anstass

  • Charles Cobbs

  • Jason Heth

  • Michael Salacz

  • Stacy D'Andre

  • Robert Aiken

  • Yaron Moshel

  • Jooyeon Nam

  • Clement Pillainayagam

  • Stephanie Wagner

  • Kevin Walter

  • Rekha Chaudary

  • Samuel Goldlust

  • Ian Lee

  • Daniela Bota

  • Heinrich Elinzano

  • Jai Grewal

  • Kevin Lillehei

  • Tom Mikkelsen

  • Tobias Walbert

  • Steve Abram

  • Andrew Brenner

  • Matthew Ewend

  • Simon Khagi

  • Darren Lovick

  • Jana Portnow

  • Lyndon Kim

  • William Loudon

  • Nina Martinez

  • Reid Thompson

  • David Avigan

  • Karen Fink

  • Francois Geoffroy

  • Pierre Giglio

  • Oleg Gligich

  • Dietmar Krex

  • Scott M Lindhorst

  • Jose Lutzky

  • Hans-Joerg Meisel

  • Minou Nadji-Ohl

  • Lhagva Sanchin

  • Andrew Sloan

  • Marnix Bosch

Medical Centers

  • University of Cincinnati, Cincinnati, Ohio, USA

  • Jefferson University, Philadelphia, PA, USA

  • University of North Carolina, Durham, NC, USA

  • Atlantic Healthcare, Summit, NJ, USA

  • UNIVERSITY OF MICHIGAN, Ann arbor, MI, USA

  • Hackensack University, Hackensack, NJ, USA

  • Rush Medical College, Chicao, IL, USA

  • Advent Health, Kansas City, KS, USA

  • Bergmannstrost, Halle, Germany

  • The University of Florida, Gainesville, FL, USA

  • The Ohio State University, Columbus, OH, USA

  • St. Thomas Hospital, Nashville, TN, USA

  • University of Colorado, Denver, CO, USA

  • University of Pennsylvania, Philadelphia, PA, USA

  • Northwest Biotherapeutics, Inc, Bethesda, MD, USA

  • UNIVERSITY OF ROCHESTER, ROCHESTER, NY, USA

  • Henry Ford Health, Detroit, MI, USA

  • Dartmouth University, Hanover, NH, USA

  • Department of Pathology and Department of Neurosurgery, Case Western Reserve University and University Hospitals Cleveland Medical Center; Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, USA

  • Columbus Regional Health, Columbus, IN, USA

  • St. Joseph's Hospital, Orange, CA, USA

  • Medical University of South Carolina, Charleston, SC, USA

  • Department of Neurosurgery, University of Dresden, Dresden, Germany

  • University of California, Los Angeles, Los Angeles, CA

  • Abbott Northwestern Hospital, Minneapolis, USA

  • Klinikum der Landeshauptstadt Stuttgart, Stuttgart, Germany

  • Rhode Island Hospital, Providence, RI, USA

  • University of California Irvine, Irvine, CA, USA

  • Washington University, St Louis, MO, USA

  • KINGS COLLEGE HOSPITAL, London, United Kingdom,

  • Baylor University Medical Center, Dallas, Texas, USA

  • Rutgers University, New Brunswick, NJ, USA

  • Ohio State University Comprehensive Cancer Center, Columbus, OH, USA

  • Vanderbilt University, Nashville, TN, USA

  • Mayo Clinic, Department of Oncology, Rochester, MN, USA

  • University of Miami, Miami, FL, USA

  • Mayo Clinic, Rochester, MN, USA

  • City of Hope, Duarte, CA, USA

  • Beth Israel Deaconess Medical Center, Cambridge, MA, USA

  • Division of Neuro-Oncology, New York-Presbyterian/Columbia University Medical Center, New York, NY, USA

  • Illinois Cancer Care, Peoria, IL, USA

  • Mount Sinai Hospital, New York, NY, USA

  • Swedish Hospital, Seattle, WA, USA

  • UT Health San Antonio, San Antonio, Texas, USA

  • Mount Sinai South Nassau Hospital, Oceanside, NY, Oceanside, NY, USA

  • Mount Sinai Medical Center, Miami Beach, FL, USA

Locations

  • United States

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • N/A

Drug/Treatment

  • Dendritic cell vaccine

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Cross Over

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A